NASDAQ : ELAB
PMGC Holdings Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 2.64 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.14M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
PMGC Holdings Inc. (ELAB) reported revenue of 2.58M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 2.58M | 590.08K | 766.28K | 827.00 | ||
| Cost of Revenue | 3.11M | 1.62M | 318.97K | 88.00 | ||
| Gross Profit | -528.82K | -1.03M | 447.31K | 739.00 | ||
| Selling, General & Admin | 10.59M | 5.79M | 3.34M | 1.04M | 1.95M | 659.78K |
| Research & Development | 405.18K | 147.01K | 104.65K | 7.41K | 209.74K | 123.63K |
| Operating Expenses | 11.59M | 6.09M | 3.45M | 1.04M | 2.16M | 785.80K |
| Operating Income | -12.12M | -7.12M | -3.45M | -1.04M | -1.71M | -785.06K |
| Interest Expense | -2.21M | -547.13K | -735.20K | -2.63K | ||
| Interest & Investment Income | 215.69K | 133.58K | 12.89K | 5.56K | 7.70K | |
| Currency Exchange Gain (Loss) | -26.32K | -5.24K | -5.85K | -6.13K | -2.75K | 323.00 |
| Other Non Operating Income (Expenses) | 778.39K | -6.09K | 160.83K | -612.35K | -86.76K | |
| EBT Excluding Unusual Items | -13.37M | -7.55M | -4.02M | -1.66M | -1.80M | -784.74K |
| Gain (Loss) on Sale of Investments | -105.65K | -329.96K | ||||
| Gain (Loss) on Sale of Assets | -95.78K | 97.18K | -1.55K | |||
| Other Unusual Items | 31.26K | 31.26K | ||||
| Pretax Income | -13.54M | -7.75M | -4.02M | -1.66M | -1.80M | -784.74K |
| Income Tax Expense | 30.97K | 30.97K | ||||
| Earnings From Continuing Operations | -13.57M | -7.78M | -4.02M | -1.66M | -1.80M | -784.74K |
| Earnings From Discontinued Operations | 80.53K | 32.93K | -2.23M | -2.64M | ||
| Net Income | -13.49M | -7.75M | -6.25M | -4.30M | -1.80M | -784.74K |
| Net Income to Common | -13.49M | -7.75M | -6.25M | -4.30M | -1.80M | -784.74K |
| Free Cash Flow | -8.99M | -6.38M | -5.50M | -4.57M | -1.62M | -693.42K |
| Gross Margin | -20.51% | -174.95% | 58.37% | 89.36% | ||
| Operating Margin | -469.96% | -1,207.18% | -223.72% | -94,928.90% | ||
| Profit Margin | -522.97% | -1,313.00% | -234.94% | -94,889.84% | ||
| Free Cash Flow Margin | -348.44% | -1,080.55% | -211.60% | -83,847.16% | ||
| EBITDA | -11.54M | -7.03M | -3.44M | -1.03M | -1.71M | -782.30K |
| EBITDA Margin | -222.87% | |||||
| D&A For EBITDA | 574.35K | 96.66K | 12.95K | 11.65K | 6.51K | 2.76K |
| EBIT | -12.12M | -7.12M | -3.45M | -1.04M | -1.71M | -785.06K |
| EBIT Margin | -223.72% | |||||
| Revenue as Reported | 2.58M | 590.08K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 18.14M | 5.40M | 3.98M | 3.33M | 1.15M | 411.86K |
| Short-Term Investments | 821.60K | 669.98K | 1.04K | |||
| Cash & Short-Term Investments | 18.96M | 6.07M | 3.99M | 3.33M | 1.15M | 411.86K |
| Accounts Receivable | 421.86K | 245.42K | 4.18K | |||
| Other Receivables | 181.63K | 95.11K | 5.28K | 3.07K | 8.67K | 1.71K |
| Receivables | 603.49K | 340.53K | 5.28K | 3.07K | 12.85K | 1.71K |
| Inventory | 932.51K | 95.10K | 230.15K | 160.82K | ||
| Prepaid Expenses | 333.60K | 363.31K | 867.42K | 902.05K | 153.42K | 31.18K |
| Other Current Assets | 1.19M | 687.47K | 30.96K | |||
| Total Current Assets | 20.83M | 6.87M | 6.05M | 4.92M | 1.55M | 636.52K |
| Property, Plant & Equipment | 6.70M | 2.13M | 1.09K | 1.74K | 330.09K | 29.73K |
| Long-Term Investments | 139.08K | |||||
| Goodwill | 3.04M | 977.77K | ||||
| Other Intangible Assets | 5.99M | 2.89M | 2.80M | |||
| Other Long-Term Assets | 268.73K | 10.77K | ||||
| Total Assets | 36.56M | 12.87M | 8.99M | 5.19M | 1.89M | 666.25K |
| Accounts Payable | 1.27M | 697.63K | 481.00K | 134.01K | 210.84K | 98.17K |
| Accrued Expenses | 33.86K | 93.93K | ||||
| Short-Term Debt | 9.08M | 1.25M | ||||
| Current Portion of Long-Term Debt | 85.00K | |||||
| Current Portion of Leases | 694.22K | 247.63K | 110.62K | |||
| Other Current Liabilities | 4.29M | 1.66M | 1.32M | 1.16M | 232.95K | 23.52K |
| Total Current Liabilities | 15.33M | 3.94M | 1.80M | 1.30M | 588.27K | 215.62K |
| Long-Term Debt | 85.00K | |||||
| Long-Term Leases | 4.47M | 972.84K | 172.60K | |||
| Long-Term Deferred Tax Liabilities | 30.97K | 30.97K | ||||
| Other Long-Term Liabilities | 534.47K | 65.49K | ||||
| Total Liabilities | 19.83M | 5.03M | 2.33M | 1.36M | 760.87K | 215.62K |
| Common Stock | 615.00 | 8.00 | 1.00 | 1.00 | 957.00 | 952.00 |
| Additional Paid-In Capital | 45.66M | 28.86M | 19.93M | 10.85M | 3.85M | 1.37M |
| Retained Earnings | -28.93M | -21.02M | -13.27M | -7.02M | -2.72M | -922.11K |
| Comprehensive Income & Other | -2.34K | -337.00 | 202.00 | 111.00 | 202.00 | |
| Total Common Equity | 16.74M | 7.84M | 6.66M | 3.83M | 1.13M | 450.24K |
| Shareholders' Equity | 16.74M | 7.84M | 6.66M | 3.83M | 1.13M | 450.63K |
| Total Liabilities & Equity | 36.56M | 12.87M | 8.99M | 5.19M | 1.89M | 666.25K |
| Total Debt | 14.24M | 2.64M | 283.22K | |||
| Net Cash (Debt) | 4.73M | 3.43M | 3.99M | 3.33M | 871.68K | 411.86K |
| Filing Date Shares Outstanding | 809.58K | 115.91K | ||||
| Working Capital | 5.50M | 2.93M | 4.25M | 3.62M | 963.05K | 420.90K |
| Tangible Book Value | 7.71M | 3.97M | 3.86M | 3.83M | 1.13M | 450.24K |
| Machinery | 2.07M | 891.03K | 2.60K | 2.82K | 61.64K | 32.48K |
| Leasehold Improvements | 48.02K | 48.02K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -13.49M | -7.75M | -6.25M | -4.30M | -1.80M | -784.74K |
| Depreciation & Amortization | 574.35K | 96.66K | 12.95K | 11.65K | 6.51K | 2.76K |
| Other Amortization | 500.00K | 500.00K | ||||
| Loss (Gain) From Sale of Assets | 95.78K | 32.43K | 1.55K | |||
| Loss (Gain) From Sale of Investments | 105.65K | 329.96K | ||||
| Stock-Based Compensation | 206.60K | -19.16K | 97.17K | 487.74K | 171.87K | 142.35K |
| Provision & Write-off of Bad Debts | 56.95K | 55.38K | ||||
| Other Operating Activities | 1.36M | 230.54K | 396.97K | 68.51K | 22.03K | 600.00 |
| Change in Accounts Receivable | 533.84K | -100.59K | -12.97K | -23.22K | -11.55K | -1.35K |
| Change in Inventory | -154.01K | 147.87K | -403.30K | -265.52K | -69.33K | -160.82K |
| Change in Accounts Payable | 2.21M | 957.76K | 207.50K | 466.89K | 65.19K | 192.09K |
| Change in Other Net Operating Assets | -167.48K | -416.91K | 460.43K | -1.00M | 28.12K | -51.82K |
| Operating Cash Flow | -8.21M | -5.93M | -5.49M | -4.56M | -1.59M | -660.93K |
| Capital Expenditures | -777.77K | -442.25K | -9.16K | -11.19K | -35.53K | -32.48K |
| Sale of Property, Plant & Equipment | 3.50K | |||||
| Cash Acquisitions | -8.01M | -2.16M | ||||
| Sale (Purchase) of Intangibles | -6.00K | -462.32K | ||||
| Investment in Securities | -128.49K | -26.84K | -139.08K | |||
| Other Investing Activities | -127.30K | |||||
| Investing Cash Flow | -8.92M | -2.77M | -610.56K | -11.19K | -32.03K | -32.48K |
| Short-Term Debt Issued | 914.44K | 183.97K | ||||
| Total Debt Issued | 353.47K | 914.44K | 183.97K | |||
| Short-Term Debt Repaid | -1.15M | |||||
| Total Debt Repaid | -301.58K | -1.15M | ||||
| Net Debt Issued (Repaid) | 51.88K | -235.56K | 183.97K | |||
| Issuance of Common Stock | 6.07M | 10.12M | 6.99M | 6.74M | 25.00K | |
| Repurchase of Common Stock | -179.00 | |||||
| Other Financing Activities | 23.46M | -33.13K | ||||
| Financing Cash Flow | 29.58M | 10.12M | 6.76M | 6.74M | 2.36M | 1.09M |
| Foreign Exchange Rate Adjustments | 2.92K | 177.00 | -2.35K | 1.06K | -1.31K | 1.35K |
| Net Cash Flow | 12.46M | 1.42M | 657.60K | 2.17M | 743.04K | 398.51K |
| Free Cash Flow | -8.99M | -6.38M | -5.50M | -4.57M | -1.62M | -693.42K |
| Free Cash Flow Margin | -348.44% | -1,080.55% | -211.60% | -83,847.16% | ||
| Levered Free Cash Flow | -4.13M | -2.76M | -2.95M | -1.02M | -839.94K | -400.02K |
| Unlevered Free Cash Flow | -2.75M | -2.42M | -2.49M | -1.02M | -838.30K | -400.02K |
| Cash Interest Paid | 172.20K | 37.77K | 69.03K | 14.40K | ||
| Change in Working Capital | 2.42M | 588.12K | 251.67K | -823.19K | 12.43K | -21.91K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 2.10M | 1.10M | 7.03M | 30.10M | ||
| Enterprise Value | -2.62M | -3.10M | 570.61K | 29.86M | ||
| Last Close Price | 2.60 | 355.20 | 13,465.20 | 2,150,065.00 | ||
| PS Ratio | 0.82 | 1.87 | ||||
| PB Ratio | 0.10 | 0.14 | 1.05 | 7.87 | ||
| P/TBV Ratio | 0.27 | 0.28 | 1.82 | 7.87 | ||
| Debt / Equity Ratio | 0.85 | 0.34 | 0.25 | |||
| Net Debt / Equity Ratio | -0.28 | -0.44 | -0.60 | -0.87 | -0.77 | -0.91 |
| Net Debt / EBITDA Ratio | 0.41 | 0.49 | 1.16 | 3.22 | 0.51 | 0.53 |
| Net Debt / FCF Ratio | 0.53 | 0.54 | 0.72 | 0.73 | 0.54 | 0.59 |
| Asset Turnover | 0.11 | 0.05 | 0.60 | 0.00 | ||
| Inventory Turnover | 1.63 | |||||
| Quick Ratio | 1.28 | 1.63 | 2.22 | 2.57 | 1.99 | 1.92 |
| Current Ratio | 1.36 | 1.74 | 3.36 | 3.79 | 2.64 | 2.95 |
| Return on Equity (ROE) | -105.22% | -107.34% | -76.61% | -66.83% | -227.60% | -367.53% |
| Return on Assets (ROA) | -32.98% | -40.73% | -30.40% | -18.42% | -83.76% | -143.62% |
| Return on Capital Employed (ROCE) | -57.10% | -79.80% | -47.90% | -26.80% | -131.50% | -174.20% |
| Earnings Yield | -3,838.11% | -703.63% | -88.86% | -14.29% | ||
| FCF Yield | -426.88% | -579.06% | -78.19% | -15.18% |